After the Cutbacks: Does ZOOZ Still Have a Flywheel Business, or Only an Option?
The main article already showed that the flywheel leg had been pushed to the margin after the bitcoin pivot. This follow-up isolates what is actually left after the cutbacks: a patent base and a small engineering team around one demo order, against zero current revenue, heavy write-downs, and no active go-to-market engine.
The main article already argued that by the end of 2025 ZOOZ's flywheel leg had been reduced mainly to an option beside the new bitcoin treasury story. This follow-up isolates one narrower question: after the deep cost cutting, is there still an operating business here, or mainly a piece of technology waiting for a new route to monetization.
The short answer: for now, it is still mostly an option. Not an empty option, because there are patents, a small development team, and one system sent for a demo. But not an active business either. The filing describes zero current revenue, no new system sales in the second half, heavy inventory and equipment write-downs, and a workforce with no sales and marketing layer.
That distinction matters because it determines how the legacy activity should be valued in the reader's head. If it is still a business, it deserves some credit for a future return to revenue. If it is only an option, that credit stays limited until a real commercial proof point appears. The 2025 filing still does not provide that proof point.
What Is Actually Left Of The Activity
The first number worth holding in mind is not the patent count, but the revenue line. The flywheel activity generated only $247 thousand of revenue in 2025. That is small even for a very small company, but the harsher point comes from the risk language: during the second half of 2025, no additional ZOOZTER-100 systems were sold, and as of the report date the company does not currently generate revenue.
That no longer looks like a business caught in a temporary timing gap. It looks like an activity whose commercial motion stopped and was placed into a holding pattern. The picture becomes clearer when inventory and equipment are added:
In 2025 the company recorded $2.888 million of inventory write-offs, versus $457 thousand in 2024 and $1.267 million in 2023. Inside that number sat another $1.171 million of raw materials not expected to be used, because the company does not actively market these systems and does not expect to recover them. On top of that, it recorded a $453 thousand loss on property and equipment disposals because it does not anticipate manufacturing additional systems in the foreseeable future.
This is the center of the read. A business that is only in a cyclical trough usually preserves its platform for the recovery. Here something else happened: the company marked down both the inventory already on hand and part of the equipment that had been built for a wider commercialization effort. This is not only weak demand. It is an admission that the operating base once built for scale is no longer being treated as economically useful in the same way.
The Headcount Tells You What Kind Of Asset This Is
The human-capital section makes the same point from another angle. As of December 31, 2025, ZOOZ had 8 employees in Israel, plus its CEO engaged through a consulting agreement. Of the 8 Israel-based employees, 6 were in research and development, 1 was in operations, and 1 was in general and administrative functions.
What is missing matters as much as what remains. There is no sales and marketing layer. There is no broader commercial layer. Even the five contractors and service providers mentioned in the same section are there mainly for support functions, including controller services, ERP support, and IT services, not for building a go-to-market engine.
That connects directly to the R&D section. After the transition to bitcoin and the restructuring program, the company says it maintained a small team focused on developing its flywheels and power-booster systems while exploring possible additional uses for the technology. That is the language of IP preservation and engineering continuity. It is not the language of a company that still has an active commercial channel.
So the correct read of the workforce is not simply that the company became more efficient. The better read is that the company changed the type of asset it still carries. Instead of a business trying to scale, it is now holding a technical core meant to keep the option alive until a new commercialization route appears.
SMYZE Is A Feasibility Test, Not Proof Of A Market
If the filing contains one positive commercial thread, it is the SMYZE Intelligent Technology order in Shanghai. In January 2025, ZOOZ received a purchase order for one ZOOZTER-100 system for demo purposes, with an option to purchase that system on terms to be agreed between the parties. The system was installed in September 2025.
But the weight of that order depends on reading it all the way through. This is not a follow-on order. It is not a priced commercial framework. It is also not an entirely independent customer signal: the counterparty is controlled by Fang Zheng, who at the time served as a ZOOZ director and was the majority shareholder of Keyarch Global. The filing also notes that the shipment followed audit-committee and board approval.
| Evidence | What business proof would look like | What the filing actually gives |
|---|---|---|
| New sales in the second half | More systems sold and a growing installed base | Zero new sales |
| Revenue status today | Ongoing revenue, even if small | The company says it currently generates no revenue |
| Commercial layer | At least a minimal sales, marketing, and operations setup | No sales and marketing layer, and only one operations employee |
| SMYZE | A commercial contract or repeat order | One demo system, with an option to purchase on terms still to be agreed |
| What still has value | A customer base that is expanding | Patents, a small development team, and support for already installed systems |
That does not make SMYZE worthless. It does make it optional. If the demo converts into a full purchase or opens the door to additional orders, it can become a real starting point. But as of the end of 2025 it is not yet doing that work. Without agreed economics, a repeat order, or another independent third-party customer, this is closer to a feasibility test than to proof that a flywheel market is already reopening.
Why Management Itself Uses The Language Of Strategic Alternatives
The filing does not describe a relaunch that is already underway. It describes a search. The repeated language is about "strategic alternatives" meant to fully capitalize on the flywheel technology. That phrasing matters because it comes together with three explicit caveats: additional funding may be required, additional personnel may need to be hired, and there is no guarantee the company will identify a successful alternative or that such an alternative will improve its financial position.
In other words, management is not presenting a commercialization path that survived the restructuring intact. It is presenting a technical asset that is still searching for its next route. That is a big distinction. An active business should be able to show a mechanism that translates technology into revenue. A technology option first has to prove that such a mechanism can be rebuilt at all.
It is also important not to go to the opposite extreme. What remains is not zero. ZOOZ still has 26 granted patents and 5 pending patent applications, and it continues to support the systems already installed. So it would be wrong to say the legacy leg has disappeared. But it would also be wrong to say that what remains is a functioning commercial business. For now, what remains is an IP and engineering shell with only a very thin commercial trail.
Bottom Line
After the cutbacks, ZOOZ did not emerge with a leaner and more efficient flywheel business. It emerged with a leaner technology asset. That distinction is critical. A lean business would still need to show sales, a minimal commercialization layer, and some indication that manufacturing was only paused. The filing shows the opposite: zero current revenue, zero new system sales in the second half, inventory and equipment write-downs, and a workforce that is almost entirely engineering.
The fair counter-argument is that precisely because the company cut so deeply, even a small commercial success could change the picture quickly in the future. That is true. But that is exactly the definition of an option, not of a proven business.
For the read to change, three things still have to appear that the 2025 filing does not yet provide: a paid order from a customer that is not related to the company, closed commercial terms that turn a demo into revenue, and the rebuilding of a thin but real commercialization layer. Until then, what remains inside ZOOZ is mainly patents, an R&D team, and dependence on the hope that a new route can still be found.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.